New insights into epilepsy drug Retigabine

February 18, 2016, Rockefeller University Press
The proposed kinetic scheme for the activity of KV7.2/KV7.3 and the effect of Retigabine. The scheme contains five global states, which are different with respect to each other depending on the activation status of the VSD and the pore domain (P). In the scheme, VSD represents the four voltage sensors of the channel. Credit: © 2016 Corbin-Leftwich et al., 2016

A study published ahead of print in the The Journal of General Physiology has revealed new insights into Retigabine, a known pharmacological treatment for epilepsy.

Epilepsy is a family of encephalopathies characterized by abnormal synchronous and rhythmic neuronal activity in the brain that results in seizures. It is one of the most common disorders of the brain and has been diagnosed in 5.1 million people in the United States, according to the Centers for Disease Control and Prevention.

The heteromeric neuronal KV7.2/KV7.3 channel is the assembly of KV7 subunits most commonly found in the central nervous system. Mutations that detrimentally affect the function of neuronal KV7 channels cause hyperexcitability syndromes such as benign familial neonatal seizures, early onset epileptic encephalopathy, and peripheral nerve hyperexcitability. Pharmacotherapeutic approaches using drugs such as Retigabine have therefore been implemented to boost the activity of KV7 channels.

However, detailed understanding of the molecular basis for the role of neuronal KV7 channels in hyperexcitability syndromes has been lacking.

In their study using Xenopus laevis oocytes, Aaron Corbin-Leftwich, an undergraduate student at Virginia Commonwealth University, School of Medicine in Richmond, VA, under Carlos A. Villalba-Galea, PhD, assistant professor in the Department of Physiology and Biophysics, and colleagues found that Retigabine reduces excitability by enhancing the resting potential open state stability of KV7.2/KV7.3 channels. The stabilization of the channels that are already opened at neuronal resting potential levels is the clinically relevant effect of the anticonvulsant.

"Retigabine binds to KV7 proteins, causing them to stay open for longer. This allows for a larger flow of potassium ions that are leaving the neuron," the authors note. "This increases the magnitude of the stimulation required to excite neurons, decreasing the chance of spontaneous activity, and reducing unwanted electrical signals."

These findings may help in further refinement of the available pharmacotherapy for KV7-related encephalopathies, as well as for the design of new ones.

Explore further: Scientists explore a new approach to prevent newborn epilepsies

More information: Aaron Corbin-Leftwich et al. Retigabine holds K 7 channels open and stabilizes the resting potential , The Journal of General Physiology (2016). DOI: 10.1085/jgp.201511517

Related Stories

Scientists explore a new approach to prevent newborn epilepsies

November 23, 2015
Using the substance bumetanide in newborn mice, the scientists succeeded in attenuating the disease progression, allowing the animals to develop almost normally. These research results could pave the way for the development ...

Researchers find anti-seizure drug may reduce alcohol consumption

April 17, 2014
Researchers from Boston University School of Medicine (BUSM) have discovered that the anti-seizure drug ezogabine, reduced alcohol consumption in an experimental model. The findings, reported in the American Journal of Drug ...

Seizures and sudden death: When SUMO 'wrestles' potassium channels

September 3, 2014
A gene crucial for brain and heart development may also be associated with sudden unexplained death in epilepsy (SUDEP), the most common cause of early mortality in epilepsy patients.

Scientists find evidence of a biological trigger for high blood pressure

April 25, 2012
(Medical Xpress) -- Scientists have identified what could be a biological tipping point in the development of high blood pressure, in a discovery that could one day lead to new treatment.

Quiet that ringing in the brain: New drug promises relief from epilepsy and tinnitus with fewer side effects

June 23, 2015
A new drug may treat epilepsy and prevent tinnitus by selectively affecting potassium channels in the brain, UConn neurophysiologist Anastasios Tzingounis and colleagues report in the 10 June Journal of Neuroscience.

New discovery throws light on blood pressure regulation

July 11, 2011
Researchers have discovered that a protein found in the walls of blood vessels plays a key role in maintaining healthy blood pressure; a discovery that could one day lead to new treatments for people with high blood pressure.

Recommended for you

New neurons in the adult brain are involved in sensory learning

February 23, 2018
Although we have known for several years that the adult brain can produce new neurons, many questions about the properties conferred by these adult-born neurons were left unanswered. What advantages could they offer that ...

Do you see what I see? Researchers harness brain waves to reconstruct images of what we perceive

February 22, 2018
A new technique developed by neuroscientists at the University of Toronto Scarborough can, for the first time, reconstruct images of what people perceive based on their brain activity gathered by EEG.

Neuroscientists discover a brain signal that indicates whether speech has been understood

February 22, 2018
Neuroscientists from Trinity College Dublin and the University of Rochester have identified a specific brain signal associated with the conversion of speech into understanding. The signal is present when the listener has ...

Study in mice suggests personalized stem cell treatment may offer relief for multiple sclerosis

February 22, 2018
Scientists have shown in mice that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be able to help repair damage caused by multiple sclerosis ...

Nolan film 'Memento' reveals how the brain remembers and interprets events from clues

February 22, 2018
Key repeating moments in the film give viewers the information they need to understand the storyline. The scenes cause identical reactions in the viewer's brain. The results deepen our understanding of how the brain functions, ...

Biomarker, clues to possible therapy found in novel childhood neurogenetic disease

February 22, 2018
Researchers studying a rare genetic disorder that causes severe, progressive neurological problems in childhood have discovered insights into biological mechanisms that drive the disease, along with early clues that an amino ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.